New fund invests in small cap biotechnology stocks.
Parsing the performance and holdings of different biotech funds.
None of the sector ETFs managed to eke out a positive return during the month.
February was awful for sectors, with just one fund recording positive returns.
The volatile segment struggled to catch a break, then rallied, and now sits in the limelight of a virus outbreak.
Sector ETFs had a great month, with most seeing positive returns.
A few sector ETFs faltered during the month
Sector ETFs did fairly well during the month, with a few exceptions
Sector ETFs recorded largely positive performance during July.